Alyeska Investment Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-501,355
| Closed | -$2.31M | – | 417 |
|
|
2023
Q3 | $2.31M | Buy |
+501,355
| New | +$2.31M | 0.02% | 369 |
|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$1.01M | – | 417 |
|
|
2022
Q4 | $1.01M | Buy |
+100,000
| New | +$1.01M | 0.01% | 347 |
|
|
2022
Q3 | – | Sell |
-746,652
| Closed | -$7.95M | – | 372 |
|
|
2022
Q2 | $7.95M | Sell |
746,652
-985,160
| -57% | -$10.5M | 0.09% | 236 |
|
|
2022
Q1 | $16.9M | Buy |
1,731,812
+314,449
| +22% | +$3.07M | 0.19% | 161 |
|
|
2021
Q4 | $20.3M | Buy |
1,417,363
+1,345,543
| +1,873% | +$19.2M | 0.23% | 131 |
|
|
2021
Q3 | $1.44M | Sell |
71,820
-153,180
| -68% | -$3.07M | 0.02% | 556 |
|
|
2021
Q2 | $4.95M | Buy |
225,000
+25,000
| +13% | +$550K | 0.06% | 351 |
|
|
2021
Q1 | $6.79M | Sell |
200,000
-50,000
| -20% | -$1.7M | 0.09% | 263 |
|
|
2020
Q4 | $10.1M | Buy |
+250,000
| New | +$10.1M | 0.14% | 192 |
|